Results 271 to 280 of about 2,021,559 (378)
Prognostic significance of unintentional weight loss in heart failure with preserved ejection fraction. [PDF]
Ibe T+7 more
europepmc +1 more source
Cardiovascular disease (CVD) and cancer are leading causes of death worldwide, with overlapping risk factors and pathophysiological mechanisms. This review explores shared pathways, including metabolic dysregulation, chronic inflammation, and gut microbiome alterations, highlighting dual‐benefit strategies such as lifestyle modifications and repurposed
Shihan Xiang+6 more
wiley +1 more source
Early Echocardiographic Markers in Heart Failure with Preserved Ejection Fraction. [PDF]
Tavernese A+11 more
europepmc +1 more source
Quantitative Electron Beam‐Single Atom Interactions Enabled by Sub‐20‐pm Precision Targeting
Atomic lock‐on (ALO) is a rapid, low‐dose in situ technique in scanning transmission electron microscopy (STEM) that achieves sub‐20 picometer (pm) beam positioning. A sparse annular scan collects positional information while avoiding irradiation of the target site.
Kevin M. Roccapriore+2 more
wiley +1 more source
EBBP expression is significantly upregulated in DOX‐treated cardiomyocytes. Mechanistically, EBBP interacts with GRP78 to mediate K63‐linked ubiquitination, thereby attenuating the inhibitory GRP78‐PERK interaction and triggering activation of the PERK‐mediated integrated stress response (ISR).
Zilong Chen+9 more
wiley +1 more source
First-phase ejection fraction is associated with myocardial fibrosis in the pressure overloaded heart. [PDF]
He S+17 more
europepmc +1 more source
MANF in cardiomyocytes interacts with BAX to impede BAX mitochondrial translocation and cytochrome c release, further stabilizing mitochondrial structure and energy supply to relieve myocardial apoptosis and hypertrophy, which indicates MANF as a novel cardioprotective factor to have a promising clinical application for myocardial hypertrophy ...
Dong Wang+13 more
wiley +1 more source
Heart failure with supranormal ejection fraction: clinical characteristics and outcomes compared to mildly reduced and preserved ejection fraction. [PDF]
Segev A+8 more
europepmc +1 more source